Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China

Transplant Immunology

Volumn 27, Issue 2-3, 2012, Pages 69-74

  Jin, Zhan Kui ^a,b   Xu, Cui Xiang ^b   Tian, Pu Xun ^a,b   Xue, Wu Jun ^a,b   Ding, Xiao Ming ^a,b   Zheng, Jin ^a,b   Ding, Chen Guang ^a   Ge, Guan Qun ^a   Mao, Tian Ci ^a   Lin, Yuan ^c  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c NANJING TECH UNIVERSITY   (China)

Author keywords

Acute rejection; Cytomegalovirus infection; Human leukocyte antigen G; Kidney transplantation; Polymorphism

Indexed keywords

HLA G ANTIGEN; MESSENGER RNA;

ACUTE GRAFT REJECTION; ADULT; ALLELE; ARTICLE; CHINA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; GRAFT REJECTION; HEREDITY; HOMOZYGOSITY; HOST RESISTANCE; HUMAN; INFECTION RISK; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; RISK FACTOR; TRANSPLANTATION TOLERANCE;

ACUTE DISEASE; ADULT; CHINA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAFT REJECTION; HLA-G ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; POLYMORPHISM, GENETIC; POSTOPERATIVE COMPLICATIONS; RISK;

EID: 84868347890     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2012.06.008     Document Type: Article

References (41)

1. Carosella E.D., Moreau P., LeMaoult J., Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008, 29:125-132.
2. Racca A.L., Veaute C.M., Bailat A.S., Gaite L., Arriola M., Hajos S.E., et al. Expression of HLA-G and MICA mRNA in renal allograft. Transpl Immunol 2009, 21:10-12.
3. Lila N., Amrein C., Guillemain R., Chevalier P., Latremouille C., Fabiani J.N., et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002, 105:1949-1954.
4. Basturk B., Karakayali F., Emiroglu R., Sozer O., Haberal A., Bal D., et al. Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation. Transplant Proc 2006, 38:571-574.
5. Creput C., Le Friec G., Bahri R., Amiot L., Charpentier B., Carosella E., et al. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Hum Immunol 2003, 64:1033-1038.
6. Brugiere O., Thabut G., Pretolani M., Krawice-Radanne I., Dill C., Herbreteau A., et al. Immunohistochemical study of HLA-G expression in lung transplant recipients. Am J Transplant 2009, 9:1427-1438.
7. Crispim J.C., Duarte R.A., Soares C.P., Costa R., Silva J.S., Mendes-Junior C.T., et al. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl Immunol 2008, 18:361-367.
8. Kaneku H. Detection of soluble HLA-G and its correlation with kidney transplant outcome. Clin Transpl 2006, 447-454.
9. Castellaneta A., Mazariegos G.V., Nayyar N., Zeevi A., Thomson A.W. HLA-G level on monocytoid dendritic cells correlates with regulatory T-Cell Foxp3 expression in liver transplant tolerance. Transplantation 2011, 91:1132-1140.
10. Zarkhin V., Talisetti A., Li L., Wozniak L.J., McDiarmid S.V., Cox K., et al. Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients. Transplantation 2010, 90:1000-1005.
11. Jin Z.K., Tian P.X., Xue W.J., Ding X.M., Pan X.M., Ding C.G., et al. Evaluation of immune status of kidney transplant recipients by combined HLA-G5 and sCD30. Zhonghua Yi Xue Za Zhi 2010, 90:2528-2531.
12. Kotton C.N., Kumar D., Caliendo A.M., Asberg A., Chou S., Snydman D.R., et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010, 89:779-795.
13. Onno M., Pangault C., Le Friec G., Guilloux V., Andre P., Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000, 164:6426-6434.
14. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., LeMaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008, 111:4862-4870.
15. Ishitani A., Geraghty D.E. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992, 89:3947-3951.
16. Carosella E.D., Moreau P., Le Maoult J., Le Discorde M., Dausset J., Rouas-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003, 81:199-252.
17. LeMaoult J., Rouas-Freiss N., Carosella E.D. Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology. Autoimmun Rev 2005, 4:503-509.
18. Harrison G.A., Humphrey K.E., Jakobsen I.B., Cooper D.W. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993, 2:2200.
19. Rousseau P., Le Discorde M., Mouillot G., Marcou C., Carosella E.D., Moreau P. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003, 64:1005-1010.
20. Hviid T.V., Hylenius S., Rorbye C., Nielsen L.G. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003, 55:63-79.
21. Hviid T.V., Rizzo R., Christiansen O.B., Melchiorri L., Lindhard A., Baricordi O.R. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004, 56:135-141.
22. Zheng X.Q., Zhu F., Shi W.W., Lin A., Yan W.H. The HLA-G 14 bp insertion/deletion polymorphism is a putative susceptible factor for active human cytomegalovirus infection in children. Tissue Antigens 2009, 74:317-321.
23. Ljungman P., Griffiths P., Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002, 34:1094-1097.
24. Hviid T.V., Hylenius S., Hoegh A.M., Kruse C., Christiansen O.B. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002, 60:122-132.
25. Lin A., Yan W.H., Xu H.H., Tang L.J., Chen X.F., Zhu M., et al. 14 bp deletion polymorphism in the HLA-G gene is a risk factor for idiopathic dilated cardiomyopathy in a Chinese Han population. Tissue Antigens 2007, 70:427-431.
26. Chen X.Y., Yan W.H., Lin A., Xu H.H., Zhang J.G., Wang X.X. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008, 72:335-341.
27. Hernandez-Fuentes M.P., Lechler R.I. A 'biomarker signature' for tolerance in transplantation. Nat Rev Nephrol 2010, 6:606-613.
28. Aghdaie M.H., Azarpira N., Kazemi K., Geramizadeh B., Darai M., Malekhoseini S.A. Frequency of HLA-G exon 8 polymorphisms and kidney allograft outcome in Iranian population. Mol Biol Rep 2011, 38:3593-3597.
29. Crispim J.C., Mendes-Junior C.T., Wastowski I.J., Costa R., Castelli E.C., Saber L.T., et al. Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome. Tissue Antigens 2008, 71:35-41.
30. Piancatelli D., Maccarone D., Liberatore G., Parzanese I., Clemente K., Azzarone R., et al. HLA-G 14-bp insertion/deletion polymorphism in kidney transplant patients with metabolic complications. Transplant Proc 2009, 41:1187-1188.
31. Torres M.I., Luque J., Lorite P., Isla-Tejera B., Palomeque T., Aumente M.D., et al. 14-Base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring. Hum Immunol 2009, 70:830-835.
32. Twito T., Joseph J., Mociornita A., Rao V., Ross H., Delgado D.H. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2011, 30:778-782.
33. Wilkinson G., Tomasec P., Stanton R.J., Armstrong M., Prod'Homme V., Aicheler R., et al. Modulation of natural killer cells by human cytomegalovirus B-4695-2008. J Clin Virol 2008, 41:206-212.
34. Wills M.R., Okecha G., Weekes M.P., Gandhi M.K., Sissons P., Carmichael A.J. Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response C-6991-2012. J Immunol 2002, 168:5455-5464.
35. Sester U., Gartner B.C., Wilkens H., Schwaab B., Wossner R., Kindermann I., et al. Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation. Am J Transplant 2005, 5:1483-1489.
36. Spencer J.V., Lockridge K.M., Barry P.A., Lin G., Tsang M., Penfold M.E., et al. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 2002, 76:1285-1292.
37. Yan W.H., Lin A., Chen B.G., Chen S.Y. Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. J Infect Dis 2009, 200:820-826.
38. Xiao L., Shi B.Y., Gao Y., He X.Y., Xu X.G., Huang H.Y., et al. Correlation of HLA-G expression with CMV active infection following kidney transplantation. Chin J Organ Transplant 2011, 32:534-538.
39. Hoffmann T.W., Halimi J.M., Buchler M., Velge-Roussel F., Goudeau A., Al Najjar A., et al. Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation. Transplantation 2008, 85:1406-1411.
40. Alakulppi N.S., Kyllonen L.E., Salo H., Partanen J., Salmela K.T., Laine J.T. The impact of donor cytokine gene polymorphisms on the incidence of cytomegalovirus infection after kidney transplantation. Transpl Immunol 2006, 16:258-262.
41. Hoffmann T.W., Halimi J.M., Buchler M., Velge-Roussel F., Goudeau A., Al-Najjar A., et al. Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation. J Med Genet 2010, 47:54-58.